Managed Healthcare Executive® State of Industry Survey: COVID-19 Vaccine Worries
The biggest concern of the respondents to our State of the Industry survey was misinformation about vaccines on social media.
Yesterday’s Supreme Court decision blocking the Biden administration’s rules that would have required large employers to impose COVID-19 vaccine mandates has damped expectations for vaccine coverage. Public health experts say it is now unlikely the country will reach the 85% to 90% vaccination rate needed to bring the pandemic under control. Today the CDC’s vaccination tally shows that 208 million Americans, or 62.8% of the population, is fully vaccinated and that 78 million, or 37.5%, have received a booster shot.
A court challenge was expected but still in the future when respondents were filling out our State of Industry survey last fall.
We asked posed five questions about concerns about the COVID-19 vaccine.
By far the biggest worry was the misinformation about the vaccines: 66% of the respondents indicated that they were very concerned about that. The survey had 100 respondents but not all the respondents answered every question.
Whether an omicron-specific vaccine is needed is now being debated. A fairly large minority of respondents to our survey had worries about the vaccines being ineffective against future variants: 28% said they were very concerned about that prospect and 7% said put themselves in the extremely concerned category.
Low vaccination rates among children and teens had similar proportions in the very and extremely concerned camps: 33% of the respondents said they were very concerned about low vaccination rates among children and 17% rated their worry level as extremely concerned. For low rates among teens, the very concerned proportion was 35% and the extremely concerned one, 20%.
Doug Chaet of Value Evolutions Discusses Value-based Payment Models, Where They Stand and More
September 29th 2022In this episode of Tuning In to the C-Suite, Managing Editor of Managed Healthcare Executive, Peter Wehrwein, speaks with President of Value Evolutions and MHE Editorial Advisory Board Member, Doug Chaet, FACHE, about value-based care's current standing, the status of select payment models like bundled and episodic, and more.
Listen
Florida Gets the OK. But Will Drug Importation from Canada Actually Happen?
March 5th 2024Canadian health officials warn that maintaining a drug supply for Canadians is their priority. The staunch opposition of the U.S. pharmaceutical industry may also be an obstacle to imports from north of the border.
Read More
We conducted our annual State of the Industry survey in the early part of November 2023. The survey had 432 respondents, of whom 56% self-reported working for a payer organization (pharmacy benefit manager, insurer or self-insured employer), 34% for a provider organization and the remainder for government or an unspecified “other” category.
Read More
